Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
135 results
  1. NLM Digital Collections - The Health Consequences of Smoking: Chronic Obstructive Lung Disease: A Report of the Surgeon ... 
    Publication: United States. Office on Smoking and Health, 1984
    resource.nlm.nih.gov/101584932X476
    ... CATALASE reduction of smoke effects on al- pha,-protease inhibitor, 436 CERULOPLASMIN prevention of alpha,-antitrypsin ox- idation, 274 CESSATION OF ...
  2. NLM Digital Collections - The Health Consequences of Smoking: Chronic Obstructive Lung Disease: A Report of the Surgeon ... 
    Publication: United States. Office on Smoking and Health, 1984
    resource.nlm.nih.gov/101584932X499
    ... CATALASE reduction of smoke effects on al- pha,-protease inhibitor, 436 CERULOPLASMIN prevention of alpha,-antitrypsin ox- idation, 274 CESSATION OF ...
  3. NLM Digital Collections - PCSK9 inhibitors for treatment of high cholesterol : effectiveness, value, and value-based ... 
    Publication: [Boston, MA] : Institute for Clinical and Economic Review, November 24, 2015
    resource.nlm.nih.gov/101672684
    ... Anticholesteremic Agents -- therapeutic use Azetidines -- therapeutic use Enzyme Inhibitors -- therapeutic use Hypercholesterolemia -- therapy Hyperlipoproteinemia Type II -- prevention & control Proprotein Convertases -- economics Serine Endopeptidases -- economics Cholesterol, LDL Cost-Benefit Analysis Decision Support ...
  4. NLM Digital Collections - Helping adolescents with HIV adhere to HAART 
    Publication: [Rockville, MD?] : [HRSA], [1999]
    resource.nlm.nih.gov/101608573
    ... Tulsky JP, Hecht FM, and Moss AR. (1997). Protease inhibitors in the homeless ... implications for prevention and policy. Child Welfare. 77:195-207. Farrow ...
  5. NLM Digital Collections - Risk estimation and the prevention of cardiovascular disease : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), June 2017
    resource.nlm.nih.gov/101714866
    ... Biondi-Zoccai G, al. Gemfibrozil for the Secondary Prevention of Coronary Heart Lhermusier T, Baker NC, et al. The impact of proprotein convertase Disease in Men with Low Levels of High-Density Lipoprotein subtilisin-kexin type 9 serine protease inhibitors on lipid levels Cholesterol. N Engl J Med ...
  6. NLM Digital Collections - Observational real-world evidence update : prophylaxis of hereditary angioedema with Takhzyro ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 24, 2021
    resource.nlm.nih.gov/9918401082906676
    ... sales price CDC Centers for Disease Control and Prevention DPP4 Dipeptidyl-peptidase ... inhibitor PCE Personal consumption expenditure PDC Proportion of days ...
  7. NLM Digital Collections - Oral Health in America: A Report of the Surgeon General (Index) 
    Publication: National Institute of Dental and Craniofacial Research (U.S.), 2000
    resource.nlm.nih.gov/101584932X156
    ... programs in, 170 strategies employed by, 156t tobacco prevention programs in, ... leukocyte protease inhibitor (SLPI), 27 Self-care. See Oral health care ...
  8. NLM Digital Collections - Oral Health in America: A Report of the Surgeon General 
    Publication: National Institute of Dental and Craniofacial Research (U.S.), 2000
    resource.nlm.nih.gov/101584932X142
    ... programs in, 170 strategies employed by, 156t tobacco prevention programs in, ... leukocyte protease inhibitor (SLPI), 27 Self-care. See Oral health care ...
  9. NLM Digital Collections - The comparative clinical effectiveness and value of simeprevir and sofosbuvir in the ... 
    Publication: [Boston, MA] : Institute for Clinical and Economic Review, April 15, 2014
    resource.nlm.nih.gov/101642256
    ... The primary goal of HCV treatment is the prevention of cirrhosis and hepatocellular carcinoma. The ... approved for treatment of ...
  10. NLM Digital Collections - Future Directions in AIDS Research (Madison, WI), 1993 July 30-31 
    https://resource.nlm.nih.gov/101647507X92
    ... continuing Teseaich with non-nucleoside reverse transcriptase inhibitors, protease inhibitors, tat inhibitors, and nucleoside reverse transcriptase inhibitors. However, ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last